Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells

Despite major advances, multiple myeloma (MM) remains an incurable malignancy. Recently we have found that disease stabilization was achieved in 64% of patients with advanced MM treated with the farnesyltransferase inhibitor R115777 (Zarnestra) in a phase 2 clinical trial. In order to enhance R11577...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Zhu, Kuichun, Gerbino, Elvira, Beaupre, Darrin M., Mackley, Paul A., Muro-Cacho, Carlos, Beam, Craig, Hamilton, Andrew D., Lichtenheld, Mathias G., Kerr, William G., Dalton, William, Alsina, Melissa, Sebti, Saïd M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: The American Society of Hematology 2005
Ämnen:
Neoplasia
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895008/
https://ncbi.nlm.nih.gov/pubmed/15728126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2004-11-4307
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk